IMCD (IMCD) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
30 Apr, 2026Executive summary
Revenue rose 6% on a constant currency basis to €1,267 million, with organic decline offset by acquisitions and FX headwinds.
Q1 2026 gross profit reached €312 million, up 1% on a constant currency basis compared to Q1 2025.
Operating EBITA was €130 million, down 2% on a constant currency basis year-over-year, reflecting organic decline and FX impact.
Free cash flow increased 19% to €121 million, driven by reduced net working capital investments.
Recent acquisitions include Dong Yang FT (South Korea) and Willows Ingredients (Ireland).
Financial highlights
Revenue for Q1 2026 was €1,267 million, up 1% year-over-year (6% FX adjusted).
Gross profit margin declined to 24.6% from 25.8% in Q1 2025.
Operating EBITA margin decreased to 10.2% from 11.3% year-over-year.
Net result was €63 million, down 8% year-over-year.
Cash earnings per share declined 6% to €1.46.
Outlook and guidance
Macroeconomic and political uncertainty, including Middle East conflict, continues to impact demand visibility.
Focus remains on earnings growth through service optimization, market position strengthening, and leveraging digital and logistics infrastructure.
Confidence in resilient business model and strong commercial teams to sustain growth.
Latest events from IMCD
- Strong 2025 results, digital innovation, and ESG leadership drive resilient growth.IMCD
Investor presentation6 Mar 2026 - Revenue up 1%, but EBITA and net profit fell amid margin pressure and higher costs.IMCD
Q4 202518 Feb 2026 - Acquisitions drove 4% revenue growth, but margins and net result declined as net debt increased.IMCD
Q2 20242 Feb 2026 - Revenue and EBITA/EBITDA rose, but margin and cash flow pressures persisted amid volatility.IMCD
Q3 202415 Jan 2026 - Double-digit EBITA growth and margin gains, led by Americas and Asia-Pacific, amid CEO transition.IMCD
Q1 202527 Dec 2025 - Revenue and EBITA rose in 2024, supported by acquisitions and resilience amid market volatility.IMCD
Q4 202417 Dec 2025 - Revenue and EBITA grew, but net result and cash flow fell as acquisitions and FX shaped H1 2025.IMCD
Q2 202516 Nov 2025 - Modest profit growth offset by margin pressure and FX headwinds; leverage remains controlled.IMCD
Q3 20256 Nov 2025